Cloning and Partial Characterization of the Humantie-2 Receptor Tyrosine Kinase Gene Promoter

This publication has 27 references indexed in Scilit:

• Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
  Proceedings of the National Academy of Sciences, 1998
• Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis.
  British Journal of Cancer, 1998
• Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth.
  Journal of Clinical Investigation, 1997
• Tie2 Expression and Phosphorylation in Angiogenic and Quiescent Adult Tissues
  Circulation Research, 1997
• Tie2 Receptor Expression and Phosphorylation in Cultured Cells and Mouse Tissues
  European Journal of Biochemistry, 1997
• Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
  Nature, 1995
• Endothelial receptor tyrosine kinases involved in angiogenesis.
  The Journal of cell biology, 1995
• Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo.
  Genes & Development, 1994
• Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system.
  Proceedings of the National Academy of Sciences, 1993
• A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains.
  Molecular and Cellular Biology, 1992